Nanobac Cash Per Share vs Capex To Depreciation Analysis
| NNBP Stock | USD 0.0001 0.00 0.00% |
Nanobac Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Nanobac Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanobac Pharmaceuticals is a good investment. Please check the relationship between Nanobac Pharmaceuticals Cash Per Share and its Capex To Depreciation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Cash Per Share vs Capex To Depreciation
Cash Per Share vs Capex To Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanobac Pharmaceuticals Cash Per Share account and Capex To Depreciation. At this time, the significance of the direction appears to have totally related.
The correlation between Nanobac Pharmaceuticals' Cash Per Share and Capex To Depreciation is 1.0. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Nanobac Pharmaceuticals Incorporated, assuming nothing else is changed. The correlation between historical values of Nanobac Pharmaceuticals' Cash Per Share and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Nanobac Pharmaceuticals Incorporated are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Cash Per Share i.e., Nanobac Pharmaceuticals' Cash Per Share and Capex To Depreciation go up and down completely randomly.
Correlation Coefficient | 1.0 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Cash Per Share
Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Most indicators from Nanobac Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanobac Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of 11/30/2024, Selling General Administrative is likely to drop to about 2.6 M. In addition to that, Discontinued Operations is likely to drop to about (54.1 K)
| 2010 | 2011 | 2023 | 2024 (projected) | Gross Profit | 8K | 3.1K | 3.6K | 3.4K | Total Revenue | 12K | 17.6K | 15.9K | 15.1K |
Nanobac Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Nanobac Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.